Clinical Research Institute of Michigan – Shores Rheumatology
Main: 586-598-3329
Study Coordinator: Amelia Laurence 586-598-3329 X 201
Study Coordinator: Latrece Keaton 586-598-3329 X 202
- Indication: Systemic Sclerosis
- Enrollment Status: Pre-Enrollment
- Protocol: 1305-0052 “Veranda”
- Drug: Nerandomilast
- Sponsor: Boehringer Ingelheim International GmbH
- Description: A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in patients with systemic sclerosis (SSc).